Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Other Non Operating Income (2020 - 2025)

BioAtla (BCAB) has disclosed Other Non Operating Income for 6 consecutive years, with -$529000.0 as the latest value for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 138.9% year-over-year to -$529000.0; the TTM value through Dec 2025 reached -$302000.0, down 107.25%, while the annual FY2025 figure was -$302000.0, 107.25% down from the prior year.
  • Other Non Operating Income hit -$529000.0 in Q4 2025 for BioAtla, up from -$2.0 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $2.3 million in Q1 2025 and bottomed at -$2.0 million in Q3 2025.
  • Average Other Non Operating Income over 5 years is $621900.0, with a median of $687000.0 recorded in 2021.
  • Year-over-year, Other Non Operating Income surged 1497.83% in 2023 and then plummeted 390.79% in 2025.
  • BioAtla's Other Non Operating Income stood at -$175000.0 in 2021, then skyrocketed by 681.14% to $1.0 million in 2022, then skyrocketed by 58.41% to $1.6 million in 2023, then decreased by 15.58% to $1.4 million in 2024, then tumbled by 138.9% to -$529000.0 in 2025.
  • According to Business Quant data, Other Non Operating Income over the past three periods came in at -$529000.0, -$2.0 million, and -$64000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.